Showing results (51-60 of 401) with videos related to
Sort By:
Pageof 41
Disease Models & Mechanisms|February 21, 2022
RAS and beyond: the many faces of the neurofibromatosis type 1 proteinCorina Anastasaki, Paola Orozco, David H GutmannTrends in Molecular Medicine|October 11, 2019
Microglia as Dynamic Cellular Mediators of Brain FunctionElizabeth C Wright-Jin, David H GutmannTrends in Neurosciences|January 15, 2013
Modeling cognitive dysfunction in neurofibromatosis-1Kelly A Diggs-Andrews, David H GutmannNeuro-Oncology Advances|July 10, 2020
Brain tumors in Neurofibromatosis type 1Amanda De Andrade Costa, David H GutmannJournal of Neuro-Oncology|January 28, 2005
Molecular pathogenesis of meningiomasArie Perry, David H Gutmann, Guido ReifenbergerHuman Molecular Genetics|October 22, 2010
Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic miceLijun Wang, David H Gutmann, Raymond P RoosThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 3, 2003
The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytesBiplab Dasgupta, Laura L Dugan, David H GutmannJournal of Neuropathology and Experimental Neurology|June 14, 2011
Comparative characterization of the human and mouse third ventricle germinal zonesSonika Dahiya, Da Yong Lee, David H GutmannOncogene|April 30, 2004
Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppressionVictoria A Robb, Wen Li, David H GutmannExperimental Neurology|April 11, 2017
Human stem cell modeling in neurofibromatosis type 1 (NF1)Michelle L Wegscheid, Corina Anastasaki, David H GutmannPageof 41